- Home
- STRM vs JAGX Comparison
STRM vs JAGX Comparison
Compare STRM & JAGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRM
- JAGX
- Stock Information
- Founded
- STRM 1989
- JAGX 2013
- Country
- STRM United States
- JAGX United States
- Employees
- STRM N/A
- JAGX N/A
- Industry
- STRM EDP Services
- JAGX Biotechnology: Pharmaceutical Preparations
- Sector
- STRM Technology
- JAGX Health Care
- Exchange
- STRM Nasdaq
- JAGX Nasdaq
- Market Cap
- STRM 16.0M
- JAGX 12.9M
- IPO Year
- STRM 1996
- JAGX N/A
- Fundamental
- Price
- STRM $4.20
- JAGX $0.90
- Analyst Decision
- STRM
- JAGX
- Analyst Count
- STRM 0
- JAGX 0
- Target Price
- STRM N/A
- JAGX N/A
- AVG Volume (30 Days)
- STRM 21.2K
- JAGX 436.9K
- Earning Date
- STRM 12-16-2024
- JAGX 03-31-2025
- Dividend Yield
- STRM N/A
- JAGX N/A
- EPS Growth
- STRM N/A
- JAGX N/A
- EPS
- STRM N/A
- JAGX N/A
- Revenue
- STRM $18,587,000.00
- JAGX $10,480,000.00
- Revenue This Year
- STRM N/A
- JAGX $18.18
- Revenue Next Year
- STRM $4.04
- JAGX $40.06
- P/E Ratio
- STRM N/A
- JAGX N/A
- Revenue Growth
- STRM N/A
- JAGX N/A
- 52 Week Low
- STRM $1.85
- JAGX $0.78
- 52 Week High
- STRM $9.75
- JAGX $21.60
- Technical
- Relative Strength Index (RSI)
- STRM 57.75
- JAGX 47.26
- Support Level
- STRM $3.87
- JAGX $0.85
- Resistance Level
- STRM $4.37
- JAGX $0.97
- Average True Range (ATR)
- STRM 0.33
- JAGX 0.07
- MACD
- STRM 0.03
- JAGX 0.00
- Stochastic Oscillator
- STRM 58.89
- JAGX 62.83
About STRM Streamline Health Solutions Inc.
Streamline Health Solutions Inc provides transformational data-driven solutions for healthcare organizations. It provides computer software-based solutions through its looking glass platform. Its solutions include coding and CDI, coding audit, and financial management solutions. It offers various services, such as custom integration services, training services, electronic image conversion and database monitoring services. It sells its solutions and services in North America to hospitals and health systems, including physician practices, through its direct sales force and its reseller partnerships.
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.